Spironolactone (INN)
Spironolactone (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Record details
Chemical name
Spironolactone (INN)
Regulatory information
Regulation
(EC) 2009/1223
Identified ingredients
Key data
Inventory links for Spironolactone (INN)
Related records for Spironolactone (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid (Tiratricol (INN)) and its salts
(2-Acetoxyethyl)trimethylammonium hydroxide (Acetylcholine) and its salts
Aminocaproic acid (INN) and its salts
Cinchophen (INN), its salts, derivatives and salts of these derivatives
Aconitum napellus L. (leaves, roots and galenical preparations)
Aconitine (principal alkaloid of Aconitum napellus L.) and its salts
Adonis vernalis L. and its preparations
What Annex II means for Spironolactone (INN)
Spironolactone (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009. No concentration limit applies — the presence of this substance in any cosmetic product placed on the EU market is not permitted regardless of use level.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
This record is linked to 1 CosIng inventory ingredient for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Spironolactone (INN)
This page summarizes one Annex II record for Spironolactone (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Spironolactone (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Spironolactone (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Spironolactone (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II